The SLC19A2 gene helps certain cells take in thiamine, also called vitamin B1, which they need to make energy and support healthy blood cells, hearing, and pancreas function. If the SLC19A2 gene does not work properly, some tissues cannot get enough thiamine even when diet is normal. This can cause a rare inherited condition often marked by anemia, diabetes, and hearing loss. Some features may improve with thiamine treatment, especially when the condition is recognized early.
What is a gene?
Genes are stretches of DNA that give cells instructions for making molecules or managing activities in the body. Some carry the code for proteins, which do much of the cell’s work. Others are used mainly to control when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can also influence how you respond to food, stress, and medicines. For a deeper look at this topic, LearnHub offers more information.
Overview
SLC19A2Gene function
What if the gene works
The SLC19A2 gene helps cells absorb thiamine, also called vitamin B1. This vitamin supports energy production and is especially important in tissues such as the bone marrow, pancreas, and inner ear.
Risk
What if the gene does not work
People with pathogenic variants in the SLC19A2 gene can develop thiamine responsive megaloblastic anemia syndrome, often with diabetes, anemia, and hearing loss. Effects can range from milder to more severe, influencing when these features appear.
Treatment
What does that mean for your treatment
With pathogenic variants in the SLC19A2 gene, treatment usually includes lifelong high dose thiamine (vitamin B1). This can improve anemia and help blood sugar control, sometimes reducing insulin needs, while hearing changes often improve less, especially if treatment starts later.
Conditions associated with SLC19A2
Gene function
What if the gene works
Many cells need a steady supply of vitamin B1 to turn food into usable energy. In your body, the SLC19A2 gene supports processes that let cells take in thiamine, also called vitamin B1. This is part of what the SLC19A2 gene does every day in your body.
The SLC19A2 gene provides instructions for a transport protein that carries thiamine from outside the cell to inside it. This is a key step in how your body moves vitamin B1 into cells for daily use.
Once thiamine enters the cell, it can be changed into an active helper that several enzymes need. These enzymes then carry out important chemical steps involved in processing nutrients.
By supplying thiamine to these pathways, the SLC19A2 gene supports the cell’s ability to get energy from sugars and some amino acids. This helps routine cell work run in a steady way.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, including variation in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change a gene’s function more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC19A2 gene can leave the thiamine transporter misshapen, unstable, or unable to reach the cell surface, so less thiamine enters certain cells. In understanding how SLC19A2 gene variants affect thiamine transport, milder changes may leave some transport activity, while more disruptive variants can greatly reduce or stop it. When both gene copies carry pathogenic variants, this causes thiamine-responsive megaloblastic anemia syndrome, and lower remaining transport activity often goes along with earlier or more pronounced features.
How variants are linked to conditions
Pathogenic variants in the SLC19A2 gene cause thiamine-responsive megaloblastic anemia syndrome, also called Rogers syndrome. People with this inherited condition often have megaloblastic anemia, diabetes, and hearing loss, although the mix and timing can differ from person to person. Finding disease-causing variants in both copies of the SLC19A2 gene can confirm the diagnosis.
A variant is not necessarily a diagnosis
Variants are a usual feature of human biology and are widely found across the general population. Most do not directly affect health and instead reflect normal human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. Still, in some situations, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SLC19A2, risk is mostly shaped by inheritance rather than lifestyle. A child is most likely to be affected when both parents carry a harmful SLC19A2 change, and the chance can be higher in families where blood relatives have children together. There is not enough evidence to say that diet, exercise, or other daily habits meaningfully change this genetic risk.
Inheritance of SLC19A2 variants
Variants in the SLC19A2 gene are inherited in an autosomal recessive pattern. This means a child usually inherits one nonworking copy from each parent, who are often healthy carriers. When both parents carry an SLC19A2 gene variant, each pregnancy has a 25% chance of the child inheriting both variants and having the condition, a 50% chance of being a carrier, and a 25% chance of inheriting neither variant. Because SLC19A2 inheritance is autosomal recessive, it affects males and females equally.
What does my SLC19A2 result mean for my family?
For families, an SLC19A2 result usually matters most in a recessive pattern, which means parents, brothers, sisters, and future children may also carry the same gene change. Full siblings of someone with SLC19A2-related illness can sometimes be affected too, while parents are often healthy carriers. Close relatives may want to learn whether the same result runs in the family, especially when planning children.
Genetic information
Genetic testing
How you find out about variants
Variants in the SLC19A2 gene are usually found with SLC19A2 genetic testing, often as part of a multigene panel or exome test. A lab studies DNA from a blood or saliva sample to look for changes in the gene, and the report shows whether a variant was found and how it is classified.
When should I consider getting a genetic test?
Testing for SLC19A2 may be worth considering when someone has the unusual combination of anemia, diabetes starting in childhood or the teen years, and hearing loss. It can also help clarify a family history of this rare inherited condition.
A genetic result is only one part of your health story
A genetic result can be helpful, but how much it explains varies by the condition and the kind of variant involved. Over time, many factors such as lifestyle, environment, age, and medical history influence how the body functions. In some conditions, especially those affected by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in the genes involved in moving, breaking down, or handling a drug can change how much of it reaches the body’s tissues and how long it stays active. This helps explain why the same treatment may work well for one person, seem less effective for another, or cause more side effects in someone else. These differences are common and are one part of the bigger picture, along with age, other health conditions, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It focuses on patterns between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body processes it. This information can support more informed and personalized treatment decisions. If you want to learn more about this topic, you can find additional information in the LearnHub.
Drugs influenced by the SLC19A2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or adjusted. Questions about side effects, vitamin B1 supplements, or any change in your medicines are best discussed with your doctor or pharmacist.
History
SLC19A2 entered the medical literature through a rare inherited condition now called thiamine responsive megaloblastic anemia syndrome, first described by Dr. Porter Rogers in the late 1960s. For years, clinicians recognized the pattern of anemia, hearing loss, and diabetes in affected families before the gene itself was identified. Initially understood only through visible traits, later recognized as tied to a specific gene, the condition became clearer in the 1990s when researchers mapped the responsible region on chromosome 1. In 1999, disease causing variants in the SLC19A2 gene were reported, linking the syndrome to a specific genetic cause. These historical steps shaped today’s understanding and helped connect older clinical observations with modern genetic testing.